Skip to content
healthcare.dev

Multi-Cell Salt

NDC 44911-0160, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Calcarea Sulphurica, Calcarea Fluorica, Calcarea Phosphorica, Ferrum Phosphoricum, Magnesia Phosphorica, Silicea, liquid, from Energique, Inc..

Product NDC
44911-0160
Status
Listed
Labeler
Energique, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE3 [hp_X]/mL
  • DIBASIC POTASSIUM PHOSPHATE3 [hp_X]/mL
  • POTASSIUM SULFATE3 [hp_X]/mL
  • SODIUM CHLORIDE3 [hp_X]/mL
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE3 [hp_X]/mL
  • SODIUM SULFATE3 [hp_X]/mL
  • CALCIUM SULFATE ANHYDROUS6 [hp_X]/mL
  • CALCIUM FLUORIDE8 [hp_X]/mL
  • TRIBASIC CALCIUM PHOSPHATE8 [hp_X]/mL
  • FERROSOFERRIC PHOSPHATE8 [hp_X]/mL
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE8 [hp_X]/mL
  • SILICON DIOXIDE8 [hp_X]/mL

Pharmacologic classes

Blood Coagulation Factor [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
44911-0160-14491101600130 mL in 1 BOTTLE, DROPPER (44911-0160-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 44911-0160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44911-0160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.